CRISPR-Cas9 Based Engineering of Actinomycetal Genomes
- 7 April 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 4 (9), 1020-1029
- https://doi.org/10.1021/acssynbio.5b00038
Abstract
Bacteria of the order Actinomycetales are one of the most important sources of pharmacologically active and industrially relevant secondary metabolites. Unfortunately, many of them are still recalcitrant to genetic manipulation, which is a bottleneck for systematic metabolic engineering. To facilitate the genetic manipulation of actinomycetes, we developed a highly efficient CRISPR-Cas9 system to delete gene(s) or gene cluster(s), implement precise gene replacements, and reversibly control gene expression in actinomycetes. We demonstrate our system by targeting two genes, actIORF1 (SCO5087) and actVB (SCO5092), from the actinorhodin biosynthetic gene cluster in Streptomyces coelicolor A3(2). Our CRISPR-Cas9 system successfully inactivated the targeted genes. When no templates for homology-directed repair (HDR) were present, the site-specific DNA double-strand breaks (DSBs) introduced by Cas9 were repaired through the error-prone nonhomologous end joining (NHEJ) pathway, resulting in a library of deletions with variable sizes around the targeted sequence. If templates for HDR were provided at the same time, precise deletions of the targeted gene were observed with near 100% frequency. Moreover, we developed a system to efficiently and reversibly control expression of target genes, deemed CRISPRi, based on a catalytically dead variant of Cas9 (dCas9). The CRISPR-Cas9 based system described here comprises a powerful and broadly applicable set of tools to manipulate actinomycetal genomes.Keywords
Funding Information
- Novo Nordisk
This publication has 56 references indexed in Scilit:
- Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetesTrends in Biotechnology, 2014
- Use of the Meganuclease I-SceI of Saccharomycescerevisiae to select for gene deletions in actinomycetesScientific Reports, 2014
- Systems biology and biotechnology of Streptomyces species for the production of secondary metabolitesBiotechnology Advances, 2013
- antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producersNucleic Acids Research, 2013
- Thoughts and facts about antibiotics: Where we are now and where we are headingThe Journal of Antibiotics, 2012
- Breaking the Code of DNA Binding Specificity of TAL-Type III EffectorsScience, 2009
- Metabolic engineering of microorganisms: general strategies and drug productionDrug Discovery Today, 2009
- Highly efficient endogenous human gene correction using designed zinc-finger nucleasesNature, 2005
- Bioactive Microbial MetabolitesThe Journal of Antibiotics, 2005
- λ Red-Mediated Genetic Manipulation of Antibiotic-Producing StreptomycesAdvances in Applied Microbiology, 2004